When Is Chemo Not Appropriate?

Adding Immunotherapy to Chemotherapy Regimen Improves Survival in Metastatic Bladder Cancer Patients

Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race

Mount Sinai Awarded Three-Year Grant to Explore Therapeutic Approaches to KRAS Mutant Lung Tumors

Mount Sinai cancer researcher receives award for lifetime achievement

Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research

Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates

Third Dose of COVID-19 Vaccine Significantly Increases Immune Responses in Most Patients With Multiple Myeloma

Molecular Treatment Is Able to Control Brain Metastasis of Different Tumors

Mount Sinai and Samuel Waxman Cancer Research Foundation to Collaborate Against the Rising Incidence of Cancer Due to Aging

Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells